The scaffold protein p62 regulates adaptive thermogenesis through ATF2 nuclear target activation

Journal: Nature Communications

Published: 2020-05-08

DOI: 10.1038/s41467-020-16230-8

Affiliations: 27

Authors: 33

Go to article
Institutions Share
Institute for Diabetes and Obesity (IDO), HMGU, Germany 0.19
Helmholtz Diabetes Center (HDC), HMGU, Germany 0.19
Cancer Metabolism and Signaling Networks Program, SBP, United States of America (USA) 0.09
Division of Cardiovascular Medicine, VU, United States of America (USA) 0.06
Helmholtz Zentrum München - German Research Center for Environmental Health (HMGU), Germany 0.06
Department of Preclinical Imaging and Radiopharmacy, Uni Tübingen, Germany 0.05
Werner Siemens Imaging Center, Uni Tübingen, Germany 0.05
University Hospital Tübingen (UKT), Uni Tübingen, Germany 0.04
Section of Molecular Physiology, UCPH, Denmark 0.04
Institute for Clinical Microbiology and Hygiene, UR, Germany 0.03
TUM Chair of Metabolic Diseases, Germany 0.02
UC Department of Psychiatry and Behavioral Neuroscience, United States of America (USA) 0.02
UC Metabolic Diseases Institute, United States of America (USA) 0.02
TUM Else Kröner-Fresenius-Zentrum für Ernährungsmedizin (EKFZ), Germany 0.02
TUM Chair of Molecular Nutritional Medicine, Germany 0.02
Arrhenius Laboratory, Stockholm University, Sweden 0.02
Department of Molecular Biosciences / The Wenner-Gren Institute (MBW), Stockholm University, Sweden 0.02
Department of Dermatology, Uni Tübingen, Germany 0.01
Novo Nordisk Research Center Indianapolis, Inc. (NNRCI), United States of America (USA) 0.01
Novo Nordisk Foundation Center for Basic Metabolic Research (CBMR), UCPH, Denmark 0.01
Department of Biology, University of Konstanz, Germany 0.01
Department of Neuronal Control of Metabolism, Max Planck Institute for Metabolism Research, Germany 0.01
Center for Endocrinology, Diabetes and Preventive Medicine (CEDP), UoC, Germany 0.01
Cluster of Excellence - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), UoC, Germany 0.01
Center for Molecular Medicine Cologne (CMMC), UoC, Germany 0.01
Department of Experimental and Clinical Pharmacology and Toxicology, Uni Tübingen, Germany 0.01
Department of Pharmacology, Toxicology and Clinical Pharmacy, Uni Tübingen, Germany 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER